• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Detailed Review of Chronic Kidney Disease.慢性肾脏病详细综述
Kidney Dis (Basel). 2020 Mar;6(2):85-91. doi: 10.1159/000504622. Epub 2019 Dec 18.
2
Can cystatin C become an easy and reliable tool for anesthesiologists to calculate glomerular filtration rate?胱抑素C能否成为麻醉医生计算肾小球滤过率的便捷可靠工具?
J Anaesthesiol Clin Pharmacol. 2015 Jan-Mar;31(1):44-8. doi: 10.4103/0970-9185.150538.
3
Cystatin C-Based Equation for Predicting the Glomerular Filtration Rate in Kidney Transplant Recipients.基于胱抑素C的肾移植受者肾小球滤过率预测方程。
Transplant Proc. 2017 Jun;49(5):1018-1022. doi: 10.1016/j.transproceed.2017.03.050.
4
Is the Chronic Kidney Disease Epidemiology Collaboration creatinine-cystatin C equation useful for glomerular filtration rate estimation in the elderly?慢性肾脏病流行病学协作组的肌酐-胱抑素 C 方程是否可用于估算老年人的肾小球滤过率?
Clin Interv Aging. 2013;8:1387-91. doi: 10.2147/CIA.S52774. Epub 2013 Oct 11.
5
Assessment of creatinine and cystatin C-based eGFR equations in Chinese older adults with chronic kidney disease.基于肌酐和胱抑素C的估算肾小球滤过率(eGFR)方程在中国老年慢性肾脏病患者中的评估
Int Urol Nephrol. 2018 Dec;50(12):2229-2238. doi: 10.1007/s11255-018-1909-7. Epub 2018 Jun 13.
6
Applicability of chronic kidney disease epidemiology collaboration equations in a Chinese population.慢性肾脏病流行病学合作方程在中国人群中的适用性。
Nephrol Dial Transplant. 2014 Mar;29(3):580-6. doi: 10.1093/ndt/gft374. Epub 2013 Dec 12.
7
Performance of the creatinine and cystatin C-based equations for estimation of GFR in Chinese patients with chronic kidney disease.基于肌酐和胱抑素C的方程在中国慢性肾脏病患者中估算肾小球滤过率的性能。
Clin Exp Nephrol. 2017 Apr;21(2):236-246. doi: 10.1007/s10157-016-1273-9. Epub 2016 Apr 28.
8
Creatinine- vs. cystatin C-based equations compared with 99mTcDTPA scintigraphy to assess glomerular filtration rate in chronic kidney disease.基于肌酐和胱抑素 C 的方程与 99mTcDTPA 闪烁显像法评估慢性肾脏病肾小球滤过率的比较。
J Nephrol. 2012 Nov-Dec;25(6):1003-15. doi: 10.5301/jn.5000083.
9
Identification and Stratification of Diabetic Kidney Disease Using Serum Cystatin C and Serum Creatinine Based Estimating Equations in Type 2 Diabetes: A Comparative Analysis.使用血清胱抑素C和血清肌酐估算方程对2型糖尿病患者糖尿病肾病进行识别与分层:一项对比分析
J Assoc Physicians India. 2015 Nov;63(11):28-35.
10
A more accurate method acquirement by a comparison of the prediction equations for estimating glomerular filtration rate in Chinese patients with obstructive nephropathy.通过比较预测方程获取更准确的方法来估算中国梗阻性肾病患者的肾小球滤过率。
BMC Nephrol. 2016 Oct 18;17(1):150. doi: 10.1186/s12882-016-0345-0.

引用本文的文献

1
Different types of anemia in patients with chronic kidney disease.慢性肾病患者的不同类型贫血
Pak J Med Sci. 2025 Jul;41(7):2017-2022. doi: 10.12669/pjms.41.7.11398.
2
Evaluation of the Protective Effects of Moringa oleifera, Zingiber officinale, and Allium sativum in a Rat Model of Chronic Kidney Disease (CKD).辣木、生姜和大蒜对慢性肾脏病(CKD)大鼠模型保护作用的评估
Cureus. 2025 May 26;17(5):e84856. doi: 10.7759/cureus.84856. eCollection 2025 May.
3
Laboratory-based surveillance of chronic kidney disease in people with private health coverage in Brazil.巴西私人医疗保险覆盖人群中慢性肾脏病的基于实验室的监测。
BMC Nephrol. 2024 May 10;25(1):162. doi: 10.1186/s12882-024-03597-9.
4
Mechanisms of inflammation modulation by different immune cells in hypertensive nephropathy.不同免疫细胞在高血压肾病中炎症调节的机制。
Front Immunol. 2024 Mar 13;15:1333170. doi: 10.3389/fimmu.2024.1333170. eCollection 2024.
5
Barriers and Facilitators to Screening for Kidney Disease Among Older Adults with Hypertension and Diabetes in Mbarara Southwestern Uganda: Healthcare Providers' Perspective.乌干达西南部姆巴拉拉地区高血压和糖尿病老年患者肾病筛查的障碍与促进因素:医疗服务提供者的视角
J Multidiscip Healthc. 2024 Feb 29;17:855-865. doi: 10.2147/JMDH.S451533. eCollection 2024.
6
Unraveling the epigenetic code: human kidney DNA methylation and chromatin dynamics in renal disease development.解析表观遗传密码:人类肾脏疾病发展过程中的 DNA 甲基化和染色质动态。
Nat Commun. 2024 Jan 29;15(1):873. doi: 10.1038/s41467-024-45295-y.
7
Vitamin D receptor (BsmI) gene polymorphism and allele frequency among chronic kidney disease patients in south Indian population.南印度人群慢性肾脏病患者中维生素D受体(BsmI)基因多态性及等位基因频率
Bioinformation. 2023 Apr 30;19(4):380-384. doi: 10.6026/97320630019380. eCollection 2023.
8
GPR97 deficiency ameliorates renal interstitial fibrosis in mouse hypertensive nephropathy.GPR97 缺乏可改善高血压肾病小鼠的肾间质纤维化。
Acta Pharmacol Sin. 2023 Jun;44(6):1206-1216. doi: 10.1038/s41401-022-01041-y. Epub 2023 Jan 12.
9
Conservative therapy is associated with worse clinical features and biochemical derangements than renal replacement therapy: a retrospective study in Kumasi, Ghana.与肾脏替代疗法相比,保守治疗与更差的临床特征和生化紊乱相关:加纳库马西的一项回顾性研究。
BMC Nephrol. 2022 Oct 26;23(1):343. doi: 10.1186/s12882-022-02951-z.
10
Nano-Technological Approaches for Targeting Kidney Diseases With Focus on Diabetic Nephropathy: Recent Progress, and Future Perspectives.聚焦糖尿病肾病的靶向治疗肾脏疾病的纳米技术方法:最新进展与未来展望
Front Bioeng Biotechnol. 2022 May 13;10:870049. doi: 10.3389/fbioe.2022.870049. eCollection 2022.

本文引用的文献

1
Identifying Important Attributes for Early Detection of Chronic Kidney Disease.识别慢性肾脏病早期检测的重要特征。
IEEE Rev Biomed Eng. 2018;11:208-216. doi: 10.1109/RBME.2017.2787480. Epub 2017 Dec 25.
2
The role of cannabinoid signaling in acute and chronic kidney diseases.大麻素信号在急性和慢性肾脏病中的作用。
Kidney Int. 2018 Aug;94(2):252-258. doi: 10.1016/j.kint.2018.01.024. Epub 2018 Apr 27.
3
Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate.预测慢性肾脏病且肾小球滤过率严重下降患者的临床结局时间。
Kidney Int. 2018 Jun;93(6):1442-1451. doi: 10.1016/j.kint.2018.01.009. Epub 2018 Mar 29.
4
Assessment of chronic kidney disease using skin texture as a key parameter: for South Indian population.以皮肤纹理为关键参数评估慢性肾脏病:针对南印度人群。
Healthc Technol Lett. 2017 May 23;4(6):223-227. doi: 10.1049/htl.2016.0098. eCollection 2017 Dec.
5
Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in Autosomal Dominant Polycystic Kidney Disease.在常染色体显性多囊肾病中,基线总肾体积和肾脏生长速度与慢性肾脏病进展相关。
Kidney Int. 2018 Mar;93(3):691-699. doi: 10.1016/j.kint.2017.09.027. Epub 2017 Dec 28.
6
Uddanam nephropathy in India: a challenge for epidemiologists.印度的乌德南姆肾病:流行病学家面临的一项挑战。
Bull World Health Organ. 2017 Dec 1;95(12):848-849. doi: 10.2471/BLT.17.196758. Epub 2017 Oct 3.
7
Effect of Patiromer on Hyperkalemia Recurrence in Older Chronic Kidney Disease Patients Taking RAAS Inhibitors.帕替洛默尔对服用 RAAS 抑制剂的老年慢性肾脏病患者高钾血症复发的影响。
Am J Med. 2018 May;131(5):555-564.e3. doi: 10.1016/j.amjmed.2017.11.011. Epub 2017 Nov 26.
8
The activin receptor is stimulated in the skeleton, vasculature, heart, and kidney during chronic kidney disease.在慢性肾脏病期间,激活素受体在骨骼、血管、心脏和肾脏中被刺激。
Kidney Int. 2018 Jan;93(1):147-158. doi: 10.1016/j.kint.2017.06.016. Epub 2017 Aug 23.
9
Chronic Kidney Disease, Basal Insulin Glargine, and Health Outcomes in People with Dysglycemia: The ORIGIN Study.慢性肾脏病、基础胰岛素甘精胰岛素与血糖异常患者的健康结局:ORIGIN研究
Am J Med. 2017 Dec;130(12):1465.e27-1465.e39. doi: 10.1016/j.amjmed.2017.05.047. Epub 2017 Aug 31.
10
In Reply to 'Kidney Disease of Unknown Cause in Agricultural Laborers (KDUCAL) Is a Better Term to Describe Regional and Endemic Kidney Diseases Such as Uddanam Nephropathy'.
Am J Kidney Dis. 2017 Apr;69(4):552-553. doi: 10.1053/j.ajkd.2016.12.007.

慢性肾脏病详细综述

Detailed Review of Chronic Kidney Disease.

作者信息

Kakitapalli Yesubabu, Ampolu Janakiram, Madasu Satya Dinesh, Sai Kumar M L S

机构信息

Department of Electrical and Electronics Engineering, Aditya Institute of Technology and Management, Tekkali, India.

Department of Electrical and Electronics Engineering, Bapatla Engineering College, Bapatla, India.

出版信息

Kidney Dis (Basel). 2020 Mar;6(2):85-91. doi: 10.1159/000504622. Epub 2019 Dec 18.

DOI:10.1159/000504622
PMID:32309290
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7154282/
Abstract

BACKGROUND

Nephropathy problems in the Udhanam region of Andhra Pradesh in India have motivated researchers to investigate the various factors related to chronic kidney disease (CKD). Initially, studies came across the markers of identification of CKD, i.e., glomerular filtration rate (GFR) and albumin creatinine rate, as global markers of identification. Cystatin C (Cys C) and its reciprocal (1/Cys C) are used to calculate GFR. This is a very easy method compared to the more accurate methods such as radiolabelled tracer clearances, which are invasive, may involve radiation, and require several hours to perform, e.g., 99-diethylene triamine penta-acetic acid (Tc-DTPA) and Cr-EDTA. This article provides the causes (or risk factors), symptoms, and complications of CKD in a clear manner such that even common people can easily understand. Once a patient is detected and proved to be affected by CKD then the patient as well as the caretakers, including doctors, must follow some constraints. Thereby it is possible to prevent CKD progression in the patient. Modern methods are needed to prevent the pathogens which are responsible for CKD.

SUMMARY

With the help of various engineering techniques one can easily design controllers to assess as well as to prevent CKD permanently. The easiest procedure for identifying CKD is to screen people. Current recommendations suggest screening of individuals with diabetes, hypertension, cardiovascular disease, and family history of kidney diseases in the course of routine health check-ups. Much work has been done in medical sciences in the area of CKD, but there is still scope for further research. From the recent studies, advanced tools such as data mining, etc., are considered to be the current trend in the area of CKD.

KEY MESSAGE

From this article, the authors propose that patients who are already affected by urinary tract infection, acute kidney injury, and a family history of CKD should be examined via some basic tests for the presence of CKD.

摘要

背景

印度安得拉邦乌德哈纳姆地区的肾病问题促使研究人员调查与慢性肾脏病(CKD)相关的各种因素。最初,研究发现了CKD的识别标志物,即肾小球滤过率(GFR)和白蛋白肌酐比值,作为全球通用的识别标志物。胱抑素C(Cys C)及其倒数(1/Cys C)用于计算GFR。与更准确的方法(如放射性示踪剂清除率)相比,这是一种非常简单的方法,后者具有侵入性,可能涉及辐射,且需要数小时才能完成,例如99-二乙三胺五乙酸(Tc-DTPA)和铬-乙二胺四乙酸(Cr-EDTA)。本文清晰地阐述了CKD的病因(或危险因素)、症状和并发症,以便普通人也能轻松理解。一旦检测到患者并证明其患有CKD,那么患者以及包括医生在内的护理人员必须遵循一些限制条件。从而有可能防止患者的CKD病情进展。需要现代方法来预防导致CKD的病原体。

总结

借助各种工程技术,人们可以轻松设计控制器,以永久评估和预防CKD。识别CKD最简单的程序是对人群进行筛查。当前建议在常规健康检查过程中对患有糖尿病、高血压、心血管疾病以及有肾病家族史的个体进行筛查。在CKD领域的医学科学方面已经做了很多工作,但仍有进一步研究的空间。从最近的研究来看,数据挖掘等先进工具被认为是CKD领域的当前趋势。

关键信息

作者从本文中提出,已经患有尿路感染、急性肾损伤以及有CKD家族史的患者应通过一些基本测试检查是否存在CKD。